mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.004 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.004 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.005 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
JQ-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.092 |
0.005 |